2017
DOI: 10.5114/kitp.2017.68740
View full text |Buy / Rent full text
|
Sign up to set email alerts
|

Abstract: IntroductionThere is no specific marker for lung cancer, but, in some lung cancer types, carcinoembryonic antigen (CEA) can reach high levels in the blood and pleural fluid.AimThis study investigated the relationship of CEA levels in blood (CEAB) and intraoperative pleural lavage fluid (CEAP) in non-small-cell lung cancer (NSCLC) with the type, stage, and extent of lung cancer.Material and methodsA total of 50 patients, who underwent surgery at our clinic due to NSCLC (group I) or benign lung pathology (group … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 15 publications
(22 reference statements)
0
1
0
Order By: Relevance
“…The carcinoembryonic antigen (CEA) had been used as biomarker of lung adenocarcinoma for many years. Tevfk's research reveals carcinoembryonic antigen (CEA) can get high concentrations in the pleural fluid and blood (Akcam et al, 2017). However, there is no specific biomarker for lung adenocarcinoma currently.…”
Section: Discussionmentioning
confidence: 99%
“…The carcinoembryonic antigen (CEA) had been used as biomarker of lung adenocarcinoma for many years. Tevfk's research reveals carcinoembryonic antigen (CEA) can get high concentrations in the pleural fluid and blood (Akcam et al, 2017). However, there is no specific biomarker for lung adenocarcinoma currently.…”
Section: Discussionmentioning
confidence: 99%